Publications by authors named "Douglas R Stack"

Claim this Profile
I
Identification of LY3522348: A Highly Selective and Orally Efficacious Ketohexokinase Inhibitor.
Timothy B Durham, Junliang Hao, Patrick Spinazze, Douglas R Stack, James L Toth

J Med Chem· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GluK1 antagonists from 6-(carboxy)phenyl decahydroisoquinoline derivatives. SAR and evaluation of a prodrug strategy for oral efficacy in pain models.
Jose A Martinez-Perez, Smriti Iyengar, Harlan E Shannon, David Bleakman, Andrew Alt, Douglas R Stack

Bioorg Med Chem Lett· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GluK1 antagonists from 6-(tetrazolyl)phenyl decahydroisoquinoline derivatives: in vitro profile and in vivo analgesic efficacy.
Jose A Martinez-Perez, Smriti Iyengar, Harlan E Shannon, David Bleakman, Andrew Alt, Douglas R Stack

Bioorg Med Chem Lett· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of pain.
Esteban Dominguez, Smriti Iyengar, Harlan E Shannon, David Bleakman, Andrew Alt, Douglas R Stack

J Med Chem· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine.
Sandra A Filla, Mark A Winter, Kirk W Johnson, David Bleakman, Michael G Bell, Douglas R Stack

J Med Chem· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis